share_log

ARS Pharmaceuticals | 10-Q/A: Quarterly report (Amendment)

SEC ·  Dec 6 16:10
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more